United States (US) Needle Biopsy Market (2025-2031) | Outlook, Size & Revenue, Industry, Growth, Forecast, Competitive Landscape, Share, Segmentation, Analysis, Trends, Companies, Value

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Needle Biopsy Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Needle Biopsy Market - Industry Life Cycle

3.4 United States (US) Needle Biopsy Market - Porter's Five Forces

3.5 United States (US) Needle Biopsy Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 United States (US) Needle Biopsy Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 United States (US) Needle Biopsy Market Revenues & Volume Share, By End user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in the United States, leading to a higher demand for needle biopsy procedures.

4.2.2 Technological advancements in needle biopsy techniques, making the procedures more accurate and less invasive.

4.2.3 Growing awareness among healthcare professionals and patients about the benefits of early cancer detection through needle biopsies.

4.3 Market Restraints

4.3.1 High cost associated with needle biopsy procedures, limiting access for some patient populations.

4.3.2 Regulatory challenges and compliance issues related to needle biopsy practices.

4.3.3 Limited reimbursement policies for needle biopsy procedures, impacting the adoption rate.

6.1 United States (US) Needle Biopsy Market, By Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Needle Biopsy Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 United States (US) Needle Biopsy Market Revenues & Volume, By Fine-needle Aspiration Biopsy, 2021- 2031F

6.1.4 United States (US) Needle Biopsy Market Revenues & Volume, By Core Needle Biopsy, 2021- 2031F

6.2 United States (US) Needle Biopsy Market, By Application

6.2.1 Overview and Analysis

6.2.2 United States (US) Needle Biopsy Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.2.3 United States (US) Needle Biopsy Market Revenues & Volume, By Thyroid Cancer, 2021- 2031F

6.2.4 United States (US) Needle Biopsy Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.2.5 United States (US) Needle Biopsy Market Revenues & Volume, By Transperineal, 2021- 2031F

6.2.6 United States (US) Needle Biopsy Market Revenues & Volume, By Transcrectal, 2021- 2031F

6.2.7 United States (US) Needle Biopsy Market Revenues & Volume, By Liver Cancer, 2021- 2031F

6.3 United States (US) Needle Biopsy Market, By End user

6.3.1 Overview and Analysis

6.3.2 United States (US) Needle Biopsy Market Revenues & Volume, By Hospital, 2021- 2031F

6.3.3 United States (US) Needle Biopsy Market Revenues & Volume, By Diagnostics & Imaging Centers, 2021- 2031F

6.3.4 United States (US) Needle Biopsy Market Revenues & Volume, By Research Laboratories & Academic Institutes, 2021- 2031F

6.3.5 United States (US) Needle Biopsy Market Revenues & Volume, By Others, 2021- 2031F

7.1 United States (US) Needle Biopsy Market Export to Major Countries

7.2 United States (US) Needle Biopsy Market Imports from Major Countries

8.1 Average waiting time for needle biopsy appointments.

8.2 Rate of adoption of advanced needle biopsy technologies.

8.3 Patient satisfaction scores related to their needle biopsy experience.

9.1 United States (US) Needle Biopsy Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 United States (US) Needle Biopsy Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 United States (US) Needle Biopsy Market Opportunity Assessment, By End user, 2021 & 2031F

10.1 United States (US) Needle Biopsy Market Revenue Share, By Companies, 2024

10.2 United States (US) Needle Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters